SCHULD Veränderung Datum
Amarin USD 0 0 2025-03
Ardelyx USD 207.61M 968K 2025-09
Baxter International USD 9.78B 68M 2025-12
Bayer EUR 36.45B 2.93B 2025-12
BioCryst Pharmaceuticals USD 828.6M 510K 2024-12
Biogen USD 6.56B 275.1M 2026-03
BioMarin Pharmaceutical USD 1.44B 833.74M 2026-03
Emergent BioSolutions USD 903.2M 495.2M 2023-06
Esperion Therapeutics USD 262.92M 1.76M 2024-09
Gilead Sciences USD 24.94B 5M 2025-12
GlaxoSmithKline GBP 19.06B 1.34B 2026-03
Halozyme Therapeutics USD 2.14B 2.01M 2026-03
Insmed USD 727.62M 275K 2026-03
Ionis Pharmaceuticals USD 2.34B 9.5M 2026-03
J&J USD 47.93B 2.14B 2025-12
Lexicon Pharmaceuticals USD 99.51M 243K 2023-12
Moderna USD 1.31B 571M 2025-12
Omeros USD 442.16M 199K 2023-09
Pfizer USD 63.73B 231M 2026-03
PTC Therapeutics USD 286.94M 2.42B 2026-03
Regeneron Pharmaceuticals USD 2.71B 300K 2026-03
Sangamo BioSciences USD 0 0 2022-06
Sarepta Therapeutics USD 1.04B 210.44M 2025-12
Teva Pharmaceutical Industries USD 17.09B 21M 2025-12
United Therapeutics USD 200M 100M 2025-03
Vertex Pharmaceuticals USD 1.99B 44M 2026-03